CBIO vs WKHS · rev $1.0M vs rev $7.9M
Crescent Biopharma, Inc. (CBIO) versus Workhorse Group Inc (WKHS) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Workhorse Group Inc (WKHS) is a auto manufacturers company listed on US.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported WKHS revenue for 2026-06-30 was $7.9M. Net income was -$40.1M. Revenue was up 82.3% from 2026-03-31 to 2026-06-30. WKHS currently screens at market cap $13.7M.
CBIO currently screens at market cap $491.3M. WKHS currently screens at market cap $13.7M.
Not investment advice. Open the CBIO and WKHS stock pages for the full models.
Not investment advice.